Total Payments
$8,038
2024 Payments
$1,525
Companies
33
Transactions
187
Medicare Patients
7,370
Medicare Billing
$529,721
Payment Breakdown by Category
Food & Beverage$7,954 (99.0%)
Education$58.49 (0.7%)
Other$25.59 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,954 | 182 | 99.0% |
| Education | $58.49 | 4 | 0.7% |
| Honoraria | $25.59 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $829.92 | 24 | $0 (2022) |
| Shire North American Group Inc | $666.47 | 12 | $0 (2019) |
| BIOTISSUE HOLDINGS INC. | $666.11 | 16 | $0 (2024) |
| Oyster Point Pharma, Inc. | $555.16 | 14 | $0 (2024) |
| RxSight Inc | $477.55 | 8 | $0 (2024) |
| Johnson & Johnson Vision Care, Inc. | $472.93 | 6 | $0 (2019) |
| Bausch & Lomb Americas Inc. | $467.92 | 14 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $455.74 | 5 | $0 (2019) |
| Lumenis BE inc | $437.80 | 1 | $0 (2023) |
| Kala Pharmaceuticals, Inc. | $415.60 | 18 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,525 | 46 | BIOTISSUE HOLDINGS INC. ($666.11) |
| 2023 | $1,352 | 22 | Lumenis BE inc ($437.80) |
| 2022 | $950.82 | 25 | Oyster Point Pharma, Inc. ($318.68) |
| 2021 | $477.04 | 25 | Kala Pharmaceuticals, Inc. ($204.92) |
| 2020 | $207.39 | 4 | CooperVision Inc. ($90.00) |
| 2019 | $1,247 | 28 | Aerie Pharmaceuticals, Inc. ($330.74) |
| 2018 | $1,146 | 19 | Bausch & Lomb, a division of Bausch Health US, LLC ($270.54) |
| 2017 | $1,133 | 18 | Shire North American Group Inc ($358.62) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $6.46 | General |
| 12/03/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: EYE CARE | ||||||
| 11/26/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Dry eyes | ||||||
| 11/23/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/19/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/15/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/15/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $10.23 | General |
| 11/08/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Ophthalmology | ||||||
| 11/04/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $6.46 | General |
| 10/29/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: Ophthalmology | ||||||
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $83.93 | General |
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $6.48 | General |
| 10/10/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $37.15 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/09/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $10.23 | General |
| 10/03/2024 | Glaukos Corporation | iStent inject Trabecular Micro-Bypass System (Device) | Food and Beverage | Cash or cash equivalent | $28.55 | General |
| Category: Glaucoma | ||||||
| 10/01/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $140.45 | General |
| Category: Glaucoma | ||||||
| 09/16/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $4.50 | General |
| 07/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $36.91 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/19/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Honoraria | In-kind items and services | $25.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/16/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Ophthalmology | ||||||
| 07/08/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $135.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,955 | 2,179 | $288,761 | $140,059 |
| 2022 | 11 | 1,952 | 2,156 | $290,287 | $138,036 |
| 2021 | 11 | 1,842 | 2,030 | $269,935 | $135,639 |
| 2020 | 10 | 1,621 | 1,816 | $226,481 | $115,987 |
Total Patients
7,370
Total Services
8,181
Medicare Billing
$529,721
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 869 | 921 | $138,150 | $72,770 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 194 | $28,324 | $17,579 | 62.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 216 | $29,160 | $13,564 | 46.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 131 | 131 | $25,938 | $12,868 | 49.6% |
| 92134 | Imaging of retina | Office | 2023 | 192 | 217 | $17,360 | $6,065 | 34.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 126 | 127 | $15,748 | $5,757 | 36.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 187 | 192 | $15,360 | $4,815 | 31.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 65 | 77 | $8,855 | $3,052 | 34.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 42 | 42 | $5,880 | $2,390 | 40.6% |
| 92250 | Photography of the retina | Office | 2023 | 32 | 32 | $2,560 | $880.63 | 34.4% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 11 | 13 | $1,001 | $178.08 | 17.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 17 | 17 | $425.00 | $140.86 | 33.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 865 | 913 | $136,950 | $73,414 | 53.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 177 | 249 | $33,626 | $15,101 | 44.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 168 | 168 | $33,292 | $14,690 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 111 | $16,206 | $9,961 | 61.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 131 | 143 | $17,732 | $6,142 | 34.6% |
| 92134 | Imaging of retina | Office | 2022 | 171 | 183 | $14,640 | $5,102 | 34.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 71 | 74 | $10,360 | $4,564 | 44.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 159 | 169 | $13,520 | $4,322 | 32.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 87 | 101 | $11,646 | $3,857 | 33.1% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 14 | 14 | $1,540 | $669.55 | 43.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 29 | 31 | $775.00 | $214.38 | 27.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 802 | 852 | $127,800 | $72,125 | 56.4% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 154 | 154 | $30,492 | $14,819 | 48.6% |
About Dr. Danielle Remington, O.D
Dr. Danielle Remington, O.D is a Optometrist healthcare provider based in Tempe, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1780098806.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Remington, O.D has received a total of $8,038 in payments from pharmaceutical and medical device companies, with $1,525 received in 2024. These payments were reported across 187 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($7,954).
As a Medicare-enrolled provider, Remington has provided services to 7,370 Medicare beneficiaries, totaling 8,181 services with total Medicare billing of $529,721. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Tempe, AZ
- Active Since 06/17/2014
- Last Updated 09/11/2025
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1780098806
Products in Payments
- XIIDRA (Drug) $900.94
- TYRVAYA (Drug) $555.16
- RESTASIS (Drug) $500.91
- Acuvue (Device) $472.93
- Rhopressa (Drug) $455.74
- Optilight (Device) $437.80
- INVELTYS (Drug) $415.60
- RXSIGHT CONTACT LENS (Device) $376.08
- VYZULTA (Drug) $362.06
- OPD-III (Device) $199.94
- RESTASIS MULTIDOSE (Drug) $196.79
- MIEBO (Drug) $183.60
- XDEMVY (Drug) $182.94
- TRAVATAN Z (Drug) $148.84
- iDose (Device) $140.45
- AdaptDx (Device) $134.04
- Syfovre (Drug) $125.00
- ZYLET (Drug) $119.49
- Tecnis Multifocal Family of 1-piece IOLS (Device) $106.16
- VUITY (Drug) $103.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Tempe
Mr. John Chrisagis, O D P C, O D P C
Optometrist — Payments: $12,733
Optometrist $12,733
Dr. George Paul, O.d, O.D
Optometrist — Payments: $9,398
Optometrist $9,398
Arlynn Roper, O.d, O.D
Optometrist — Payments: $2,988
Optometrist $2,988
Dr. Vasvi Babu, Od, OD
Optometrist — Payments: $2,348
Optometrist $2,348
Lawrence Irene, O.d, O.D
Optometrist — Payments: $2,248
Optometrist $2,248
Leon Babu, Od, OD
Optometrist — Payments: $2,205
Optometrist $2,205